Literature DB >> 23334990

Matrix metalloproteinase 13 expression in response to double-stranded RNA in human chondrocytes.

Marta Radwan1, Christos Gavriilidis, John H Robinson, Rose Davidson, Ian M Clark, Andrew D Rowan, David A Young.   

Abstract

OBJECTIVE: To investigate the mechanism of matrix metalloproteinase 13 (MMP-13) expression in chondrocytes via pattern-recognition receptors (PRRs) for double-stranded RNA (dsRNA).
METHODS: Differential expression of PRRs was determined by real-time reverse transcription-polymerase chain reaction (RT-PCR) of RNA from patients with osteoarthritis (OA) and patients with femoral neck fracture (as normal control). Isolated human articular chondrocytes and the chondrosarcoma cell line SW-1353 were activated with poly(I-C) of different molecular weights as a dsRNA mimic, and changes in gene and protein expression were monitored by real-time RT-PCR and immunoblotting, respectively.
RESULTS: The dsRNA signaling moieties Toll-like receptor 3 (TLR-3), retinoic acid-inducible gene 1 (RIG-1), and nucleotide-binding oligomerization domain-like receptor X1 were all differentially expressed in OA cartilage compared to normal cartilage, as determined by gene expression screening. Depletion of the dsRNA-sensing receptors TLR-3, RIG-1, or melanoma differentiation-associated gene 5 (MDA-5) suppressed the induction of MMP13 messenger RNA (mRNA) expression by poly(I-C), regardless of its mode of delivery. In addition, depletion of the downstream transcription factor interferon regulatory factor 3 resulted in reduced induction of MMP13 mRNA expression by poly(I-C).
CONCLUSION: Signaling by dsRNA in chondrocytes requires a range of PRRs, including TLR-3, RIG-1, and MDA-5, for the full-induction of MMP13, thus providing tight regulation of a gene critical for maintenance of cartilage integrity. Our data add to the understanding of MMP13 regulation, which is essential before such mechanisms can be exploited to alleviate the cartilage destruction associated with OA.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23334990     DOI: 10.1002/art.37868

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  15 in total

1.  MicroRNA-218-5p as a Potential Target for the Treatment of Human Osteoarthritis.

Authors:  Jun Lu; Ming-Liang Ji; Xue-Jun Zhang; Pei-Liang Shi; Hao Wu; Chen Wang; Hee-Jeong Im
Journal:  Mol Ther       Date:  2017-08-19       Impact factor: 11.454

2.  Innate immunity sensors participating in pathophysiology of joint diseases: a brief overview.

Authors:  Jiri Gallo; Milan Raska; Yrjo T Konttinen; Christophe Nich; Stuart B Goodman
Journal:  J Long Term Eff Med Implants       Date:  2014

3.  Cytokine-induced MMP13 Expression in Human Chondrocytes Is Dependent on Activating Transcription Factor 3 (ATF3) Regulation.

Authors:  Chun Ming Chan; Christopher D Macdonald; Gary J Litherland; David J Wilkinson; Andrew Skelton; G Nicholas Europe-Finner; Andrew D Rowan
Journal:  J Biol Chem       Date:  2016-12-12       Impact factor: 5.157

4.  Activation of Toll-Like Receptor 3 Induces Interleukin-1 Receptor Antagonist Expression by Activating the Interferon Regulatory Factor 3.

Authors:  Yang Liu; Chun-Fen Mo; Xing-Yan Luo; Hua Li; Hui-Jie Guo; Hai Sun; Song Hu; Li-Mei Li; Yan-Tang Wang; Shu-Xia Yang; Shan Chang; Qiang Zou
Journal:  J Innate Immun       Date:  2019-12-20       Impact factor: 7.349

5.  Genome-Wide MicroRNA and Gene Analysis of Mesenchymal Stem Cell Chondrogenesis Identifies an Essential Role and Multiple Targets for miR-140-5p.

Authors:  Matt J Barter; Maria Tselepi; Rodolfo Gómez; Steven Woods; Wang Hui; Graham R Smith; Daryl P Shanley; Ian M Clark; David A Young
Journal:  Stem Cells       Date:  2015-07-29       Impact factor: 6.277

Review 6.  The Disease-Modifying Effects of Hyaluronan in the Osteoarthritic Disease State.

Authors:  Mathew A Nicholls; Anke Fierlinger; Faizan Niazi; Mohit Bhandari
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2017-08-11

7.  Double-stranded RNA released from damaged articular chondrocytes promotes cartilage degeneration via Toll-like receptor 3-interleukin-33 pathway.

Authors:  Changwei Li; Kaizhe Chen; Hui Kang; Yufei Yan; Kewei Liu; Changjun Guo; Jin Qi; Kai Yang; Fei Wang; Lei Guo; Chuan He; Lianfu Deng
Journal:  Cell Death Dis       Date:  2017-11-02       Impact factor: 8.469

8.  Identification of MAVS as a Novel Risk Factor for the Development of Osteoarthritis.

Authors:  Jie Liu; Ling-Yun Tang; Yan-Gui Wang; Shun-Yuan Lu; En-Ning Zhang; Zhu-Gang Wang; Hong-Xin Zhang
Journal:  Aging Dis       Date:  2018-02-01       Impact factor: 6.745

9.  The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnover.

Authors:  David J Wilkinson; Antoine Desilets; Hua Lin; Sarah Charlton; Maria Del Carmen Arques; Adrian Falconer; Craig Bullock; Yu-Chen Hsu; Kristian Birchall; Alastair Hawkins; Paul Thompson; William R Ferrell; John Lockhart; Robin Plevin; Yadan Zhang; Emma Blain; Shu-Wha Lin; Richard Leduc; Jennifer M Milner; Andrew D Rowan
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

10.  Matriptase Induction of Metalloproteinase-Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple Mechanisms.

Authors:  David J Wilkinson; Hui Wang; Angela Habgood; Heather K Lamb; Paul Thompson; Alastair R Hawkins; Antoine Désilets; Richard Leduc; Torsten Steinmetzer; Maya Hammami; Melody S Lee; Charles S Craik; Sharon Watson; Hua Lin; Jennifer M Milner; Andrew D Rowan
Journal:  Arthritis Rheumatol       Date:  2017-07-05       Impact factor: 15.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.